Eliem Therapeutics slashing staff amid leadership shakeup
The Redmond-based biotech announced Bob Azelby would leave his position as CEO. The company is also pivoting the focus of its clinical pipeline.
LocalNews
0
50
The Redmond-based biotech announced Bob Azelby would leave his position as CEO. The company is also pivoting the focus of its clinical pipeline.
